Literature DB >> 9671315

Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.

E Scotet1, E Houssaint.   

Abstract

An essential feature of fibroblast growth factor receptors (FGFRs) is the existence of multiple possibilities of alternative splicing. One of these concerns sequences of the mRNA coding for the C-terminal half of Ig domain 3 which corresponds to a part of the ligand-binding site: two alternative exons, IIIb and IIIc, encode the C-terminal half of Ig domain 3. The IIIb/IIIc choice in the FGFR-2 and FGFR-3 is strictly tissue-specific, the IIIb exon being expressed exclusively in epithelial cells. We describe here a reversible switch from IIIb to IIIc for FGFR-2 and FGFR-3 under the influence of exogenous and endogenous FGF-1 or FGF-2. We observed that FGF-induced FGF receptor exon switching (i) occurred as early as 1 h after exposure to FGF (ii) was receptor-mediated (iii) was dependent on cell confluency and showed a link with the cell cycle (iv) was correlated with a reversible loss of epithelial properties. These results support a role for FGF in the regulation of expression of alternatively spliced FGFR mRNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671315     DOI: 10.1038/sj.onc.1201908

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  What a difference a day makes! The contribution of intrinsic FGF9 signalling to germline masculinisation.

Authors:  Kate L Loveland
Journal:  Asian J Androl       Date:  2010-11-15       Impact factor: 3.285

2.  Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.

Authors:  Klaus Holzmann; Thomas Grunt; Christine Heinzle; Sandra Sampl; Heinrich Steinhoff; Nicole Reichmann; Miriam Kleiter; Marlene Hauck; Brigitte Marian
Journal:  J Nucleic Acids       Date:  2011-12-12

3.  Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.

Authors:  Liqiang Xi; Andrew Feber; Vanita Gupta; Maoxin Wu; Andrew D Bergemann; Rodney J Landreneau; Virginia R Litle; Arjun Pennathur; James D Luketich; Tony E Godfrey
Journal:  Nucleic Acids Res       Date:  2008-10-16       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.